AngElle Bioengineering ApS

CVR 43155881 · Private limited company (ApS) · Active · Low risk

AngElle Bioengineering ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 1.0% over the next 12 months, which is 0.7 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 83k and a net result of DKK -58k. CEO: Irini Angelidaki.

Bankruptcy risk for AngElle Bioengineering ApS

1.0%
probability of bankruptcy within 12 months
Low risk

0.7 × the average (1.41%) · higher risk than 72% of active Danish companies

Lowest riskHighest risk

Increases the risk

Reporting classReporting class B, mikrovirksomhed · bankruptcy rate 23.5%2.7×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Equity vs. share capital2–5× · bankruptcy rate 6.3%0.72×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Restated annual reports1 · bankruptcy rate 7.1%0.81×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43155881
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
N. Jespersens Vej 15
2000 Frederiksberg
Municipality
Frederiksberg
Industry
Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio100.0%
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
RevenueDKK 0DKK 45k
Gross profitDKK -58kDKK 38k
Net profitDKK -58kDKK 38k
EquityDKK 83kDKK 141k
Total assetsDKK 83kDKK 141k
CashDKK 83k–

Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025149
1 Jan 2024 – 31 Dec 2024166
1 Jan 2023 – 31 Dec 2023164
25 Mar 2022 – 31 Dec 2022178

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOIrini AngelidakiCurrent
Owner (100%)Irini AngelidakiCurrent
FounderIrini AngelidakiCurrent

The CEOs' other companies

Irini Angelidaki – 2 other companies, of which 1 bankrupt

Address history (0 moves)

N. Jespersens Vej 15, 2000 Frederiksberg

Other companies at the same address

Similar companies in Frederiksberg

Questions and answers about AngElle Bioengineering ApS

Has AngElle Bioengineering ApS gone bankrupt?

No, AngElle Bioengineering ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of AngElle Bioengineering ApS?

Our model estimates a bankruptcy risk of 1.0% over the next 12 months (low risk), which is 0.7 times the average for Danish companies.

Who is the CEO of AngElle Bioengineering ApS?

Irini Angelidaki is the CEO of AngElle Bioengineering ApS.

When was AngElle Bioengineering ApS founded?

AngElle Bioengineering ApS was founded on 20 March 2022.

What is the equity of AngElle Bioengineering ApS?

Equity was DKK 83k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.